ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $904,517 | -56.9% | 152,790 | -45.9% | 0.00% | – |
| Q2 2023 | $2,096,669 | +22.4% | 282,570 | +55.9% | 0.00% | – |
| Q1 2023 | $1,712,661 | -42.3% | 181,234 | -35.0% | 0.00% | – |
| Q4 2022 | $2,967,324 | +81.6% | 278,622 | +25.8% | 0.00% | – |
| Q3 2022 | $1,634,000 | +8.4% | 221,408 | -29.3% | 0.00% | – |
| Q2 2022 | $1,507,000 | -49.9% | 313,268 | -46.8% | 0.00% | -100.0% |
| Q1 2022 | $3,007,000 | +267.6% | 588,470 | +332.1% | 0.00% | – |
| Q4 2021 | $818,000 | -45.3% | 136,200 | -19.2% | 0.00% | – |
| Q3 2021 | $1,495,000 | +36.7% | 168,601 | +22.0% | 0.00% | – |
| Q2 2021 | $1,094,000 | +39.0% | 138,200 | +33.8% | 0.00% | – |
| Q1 2021 | $787,000 | -59.0% | 103,300 | -58.1% | 0.00% | – |
| Q4 2020 | $1,921,000 | +450.4% | 246,287 | +584.9% | 0.00% | – |
| Q3 2020 | $349,000 | – | 35,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 37,500 | $225,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 73,366 | $441,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 56,673 | $341,000 | 0.04% |
| GOODWIN DANIEL L | 10,000 | $60,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $535,000 | 0.01% |
| EMFO, LLC | 1,666 | $10,000 | 0.01% |
| Virtu Financial LLC | 14,020 | $84,000 | 0.01% |
| Retirement Group, LLC | 1,129 | $17,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 86,866 | $522,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $4,000 | 0.00% |